Form 4: Candel Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Francesca Barone, Chief Scientific Officer of Candel Therapeutics, sold 14,051 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- Francesca Barone, the Chief Scientific Officer of Candel Therapeutics, sold 14,051 shares of the company's common stock on July 17, 2024.
- The sale was executed at a price of $6.4726 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units, as per the company's mandatory sell-to-cover policy.
- Following the transaction, Barone directly owns 159,961 shares of Candel Therapeutics.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes). It doesn't indicate positive or negative sentiment.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 07/17/2024 | Date of the stock sale transaction. |
| 07/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.